MedPath

A Study of the ECHELON Contour Curved Cutter Stapler Device in Colorectal Procedures

Terminated
Conditions
Colorectal Surgical Procedures
Interventions
Device: Echelon Contour
Registration Number
NCT05133141
Lead Sponsor
Ethicon Endo-Surgery
Brief Summary

The purpose of this study is to prospectively generate device-specific clinical data related to the performance of Echelon Contour per its instructions for use (IFU).

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
9
Inclusion Criteria
  • Elective colorectal procedure where Echelon Contour is planned to be used for transection and resection of the colon
  • Willingness to give consent and comply with all study-related evaluations and visit schedule. If the participant is less than (<) 18 years of age, the participant's parent/legal guardian must be willing to give permission for the participant to participate in the study and provide written Informed Consent for the participant. In addition, assent must be obtained from pediatric participants who possess the intellectual and emotional ability to comprehend the concepts involved in the study. If the pediatric participant is not able to provide assent (due to age, maturity and/or inability to intellectually and/or emotionally comprehend the study); the parent/legal guardian's written Informed Consent for the participant will be acceptable for the participant to be included in the study
  • Anatomical region must be of sufficient size for the device to be used
Exclusion Criteria

Preoperative

  • Females who are pregnant
  • Physical or psychological condition which would impair study participation
  • Participant previously enrolled into the study (example: participant enrolled for Hartmann's procedure then cannot be reenrolled for the Hartmann's reversal)

Intraoperative

  • Study device use not attempted

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Echelon ContourEchelon ContourThis prospective study will include the participants who plan to have an elective colorectal surgical procedure and collect clinical data in a post-market setting. Investigators will perform each procedure using the device in compliance with their standard surgical approach and the Echelon Contour instruction for use (IFU).
Primary Outcome Measures
NameTimeMethod
Number of Participants with Echelon Contour Successinteroperative

Echelon Contour success based on surgeon responses on question 1 in the surgeon reported outcome measures (SROM) will be reported. Surgeon will be asked to choose option "Yes" or "No" for following question: Did Echelon Contour provide acceptable performance considering other therapeutic alternatives?

Secondary Outcome Measures
NameTimeMethod
Number of Participants with Device-related Adverse Events (AEs)28 days post-procedure

An AE is defined as any untoward medical occurrence, regardless of its relationship to the study device or the study procedure. An untoward medical occurrence includes any new, undesirable medical experience or worsening of a pre-existing condition, which occurs throughout the duration of the clinical study.

Trial Locations

Locations (2)

Baylor Scott and White

🇺🇸

Saint Louis, Missouri, United States

Washington University

🇺🇸

Dallas, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath